Insider Trading
Track Major Insider Updates On X/Twitter
SLNO Stock Insider Trading Activity
Corporate insiders are required to disclose purchases or sales of their own stock within two business days of when they occur. Using these disclosures, we collect data on SLNO stock insider trading activity, which can give hints on whether Soleno Therapeutics Inc executives are bullish or bearish on their own company.
Recent insider purchases and sales - SLNO
| Name / Title | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
|
Pauls Matthew
|
Sale | 5937 | Mar 28, 2025 | March 31, 2025, 7:24 p.m. |
|
Yen Kristen
SEE REMARKS
|
Sale | 23475 | Mar 27, 2025 | March 31, 2025, 7:23 p.m. |
|
Yen Kristen
SEE REMARKS
|
Sale | 50156 | Mar 27, 2025 | March 31, 2025, 7:23 p.m. |
|
Yen Kristen
SEE REMARKS
|
Sale | 6891 | Mar 27, 2025 | March 31, 2025, 7:23 p.m. |
|
Yen Kristen
SEE REMARKS
|
Sale | 91 | Mar 27, 2025 | March 31, 2025, 7:23 p.m. |
|
Yen Kristen
SEE REMARKS
|
Sale | 597 | Mar 27, 2025 | March 31, 2025, 7:23 p.m. |
|
Yen Kristen
SEE REMARKS
|
Sale | 411 | Mar 27, 2025 | March 31, 2025, 7:23 p.m. |
|
Yen Kristen
SEE REMARKS
|
Sale | 2881 | Mar 27, 2025 | March 31, 2025, 7:23 p.m. |
|
Yen Kristen
SEE REMARKS
|
Sale | 1769 | Mar 27, 2025 | March 31, 2025, 7:23 p.m. |
|
Yen Kristen
SEE REMARKS
|
Sale | 3990 | Mar 27, 2025 | March 31, 2025, 7:23 p.m. |
|
Yen Kristen
SEE REMARKS
|
Sale | 5239 | Mar 27, 2025 | March 31, 2025, 7:23 p.m. |
|
Manning Meredith
Chief Commercial Officer
|
Sale | 155 | Mar 27, 2025 | March 31, 2025, 7:21 p.m. |
|
Manning Meredith
Chief Commercial Officer
|
Sale | 2599 | Mar 27, 2025 | March 31, 2025, 7:21 p.m. |
|
Manning Meredith
Chief Commercial Officer
|
Sale | 34 | Mar 27, 2025 | March 31, 2025, 7:21 p.m. |
|
Manning Meredith
Chief Commercial Officer
|
Sale | 1976 | Mar 27, 2025 | March 31, 2025, 7:21 p.m. |
|
Manning Meredith
Chief Commercial Officer
|
Sale | 37000 | Mar 27, 2025 | March 31, 2025, 7:21 p.m. |
|
Manning Meredith
Chief Commercial Officer
|
Sale | 1087 | Mar 27, 2025 | March 31, 2025, 7:21 p.m. |
|
Manning Meredith
Chief Commercial Officer
|
Sale | 225 | Mar 27, 2025 | March 31, 2025, 7:21 p.m. |
|
Manning Meredith
Chief Commercial Officer
|
Sale | 668 | Mar 27, 2025 | March 31, 2025, 7:21 p.m. |
|
Manning Meredith
Chief Commercial Officer
|
Sale | 1505 | Mar 27, 2025 | March 31, 2025, 7:21 p.m. |
|
Mackaness James H
CHIEF FINANCIAL OFFICER
|
Sale | 2717 | Mar 27, 2025 | March 31, 2025, 7:20 p.m. |
|
Mackaness James H
CHIEF FINANCIAL OFFICER
|
Sale | 387 | Mar 27, 2025 | March 31, 2025, 7:20 p.m. |
|
Mackaness James H
CHIEF FINANCIAL OFFICER
|
Sale | 8044 | Mar 27, 2025 | March 31, 2025, 7:20 p.m. |
|
Mackaness James H
CHIEF FINANCIAL OFFICER
|
Sale | 563 | Mar 27, 2025 | March 31, 2025, 7:20 p.m. |
|
Mackaness James H
CHIEF FINANCIAL OFFICER
|
Sale | 3762 | Mar 27, 2025 | March 31, 2025, 7:20 p.m. |
|
Mackaness James H
CHIEF FINANCIAL OFFICER
|
Sale | 86 | Mar 27, 2025 | March 31, 2025, 7:20 p.m. |
|
Mackaness James H
CHIEF FINANCIAL OFFICER
|
Sale | 4940 | Mar 27, 2025 | March 31, 2025, 7:20 p.m. |
|
Mackaness James H
CHIEF FINANCIAL OFFICER
|
Sale | 6498 | Mar 27, 2025 | March 31, 2025, 7:20 p.m. |
|
Mackaness James H
CHIEF FINANCIAL OFFICER
|
Sale | 25799 | Mar 27, 2025 | March 31, 2025, 7:20 p.m. |
|
Mackaness James H
CHIEF FINANCIAL OFFICER
|
Sale | 36157 | Mar 27, 2025 | March 31, 2025, 7:20 p.m. |
|
Mackaness James H
CHIEF FINANCIAL OFFICER
|
Sale | 1669 | Mar 27, 2025 | March 31, 2025, 7:20 p.m. |
|
Huang Michael F.
Sr. VP of Clinical Development
|
Sale | 371 | Mar 27, 2025 | March 31, 2025, 7:18 p.m. |
|
Huang Michael F.
Sr. VP of Clinical Development
|
Sale | 604 | Mar 27, 2025 | March 31, 2025, 7:18 p.m. |
|
Huang Michael F.
Sr. VP of Clinical Development
|
Sale | 125 | Mar 27, 2025 | March 31, 2025, 7:18 p.m. |
|
Huang Michael F.
Sr. VP of Clinical Development
|
Sale | 836 | Mar 27, 2025 | March 31, 2025, 7:18 p.m. |
|
Huang Michael F.
Sr. VP of Clinical Development
|
Sale | 19 | Mar 27, 2025 | March 31, 2025, 7:18 p.m. |
|
Huang Michael F.
Sr. VP of Clinical Development
|
Sale | 1098 | Mar 27, 2025 | March 31, 2025, 7:18 p.m. |
|
Huang Michael F.
Sr. VP of Clinical Development
|
Sale | 86 | Mar 27, 2025 | March 31, 2025, 7:18 p.m. |
|
Huang Michael F.
Sr. VP of Clinical Development
|
Sale | 1444 | Mar 27, 2025 | March 31, 2025, 7:18 p.m. |
|
Huang Michael F.
Sr. VP of Clinical Development
|
Sale | 10000 | Mar 27, 2025 | March 31, 2025, 7:18 p.m. |
|
Hirano Patricia C
SEE REMARKS
|
Sale | 73 | Mar 27, 2025 | March 31, 2025, 7:01 p.m. |
|
Hirano Patricia C
SEE REMARKS
|
Sale | 478 | Mar 27, 2025 | March 31, 2025, 7:01 p.m. |
|
Hirano Patricia C
SEE REMARKS
|
Sale | 329 | Mar 27, 2025 | March 31, 2025, 7:01 p.m. |
|
Hirano Patricia C
SEE REMARKS
|
Sale | 3198 | Mar 27, 2025 | March 31, 2025, 7:01 p.m. |
|
Hirano Patricia C
SEE REMARKS
|
Sale | 5524 | Mar 27, 2025 | March 31, 2025, 7:01 p.m. |
|
Hirano Patricia C
SEE REMARKS
|
Sale | 4199 | Mar 27, 2025 | March 31, 2025, 7:01 p.m. |
|
Hirano Patricia C
SEE REMARKS
|
Sale | 2310 | Mar 27, 2025 | March 31, 2025, 7:01 p.m. |
|
Hirano Patricia C
SEE REMARKS
|
Sale | 1418 | Mar 27, 2025 | March 31, 2025, 7:01 p.m. |
|
Hirano Patricia C
SEE REMARKS
|
Sale | 2691 | Mar 28, 2025 | March 31, 2025, 7:01 p.m. |
|
Hirano Patricia C
SEE REMARKS
|
Sale | 9253 | Mar 28, 2025 | March 31, 2025, 7:01 p.m. |